Abstract
The results of the Cardiac Arrhythmia Suppression Trial suggest that anti- arrhythmic drug prophylaxis of high grade ectopy should be avoided in post- myocardial infarction (MI) patients. However, survival of post-MI patients with sustained ventricular tachycardia and ventricular fibrillation can be improved by an aggressive approach consisting of electrophysiologic-guided drug therapy, map-guided surgery, revascularization, and use of the automatic implantable cardioverter defibrillator.
| Original language | English |
|---|---|
| Pages (from-to) | 30-41 |
| Number of pages | 12 |
| Journal | Primary Cardiology |
| Volume | 18 |
| Issue number | 2 |
| State | Published - 1992 |